Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite.
Schlingemann J, Boucley C, Hickert S, Bourasseau L, Walker M, Celdran C, Chemarin T, Pegues C, Fritzsche M, Keitel J, Goettsche A, Seegel M, Leicht S, Guessregen B, Reifenberg P, Wetzel S, Müller T, Schooren F, Schuster T, Liebhold M, Kirsch A, Krueger P, Saal C, Mouton B, Masanes S.
Schlingemann J, et al. Among authors: seegel m.
Int J Pharm. 2022 May 25;620:121740. doi: 10.1016/j.ijpharm.2022.121740. Epub 2022 Apr 11.
Int J Pharm. 2022.
PMID: 35421534
Free article.